Endurance Wealth Management’s ResMed RMD Stock Holding History

Endurance Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$31K	Hold	140	–	–	﹤0.01%	389
2023 Q1	$31K	Hold	140	–	–	﹤0.01%	395
2022 Q4	$29K	Hold	140	–	–	﹤0.01%	377
2022 Q3	$31K	Hold	140	–	–	0.01%	372
2022 Q2	$29K	Hold	140	–	–	﹤0.01%	384
2022 Q1	$34K	Hold	140	–	–	﹤0.01%	395
2021 Q4	$36K	Hold	140	–	–	﹤0.01%	389
2021 Q3	$37K	Hold	140	–	–	﹤0.01%	385
2021 Q2	$34K	Hold	140	–	–	﹤0.01%	396
2021 Q1	$27K	Buy	+140	New	+$28.1K	﹤0.01%	425

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Endurance Wealth Management's RMD Position: Q2 2023 in Review

Endurance Wealth Management held its ResMed (RMD) position steady in Q2 2023 at 140 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #389.

Endurance Wealth Management first reported a position in RMD in Q1 2021 and has held it in 10 quarters since. The position peaked at $37K in Q3 2021. 732 funds tracked by Wall St. Rank hold RMD as of Q2 2023.

Endurance Wealth Management held 140 shares of ResMed worth $31K as of Q2 2023.
Endurance Wealth Management left its ResMed share count unchanged in Q2 2023.
ResMed made up ﹤0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #389 holding.
Endurance Wealth Management first reported a position in ResMed in Q1 2021 and has held it in 10 quarters since.
Endurance Wealth Management's ResMed position peaked at $37K in Q3 2021.
732 funds tracked by Wall St. Rank held ResMed as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.